1. 119P Final results of phase II trial (MIRACULUM) of the novel PD-1 inhibitor prolgolimab in patients with advanced melanoma. (15th December 2019) Authors: Tjulandin, S; Fedyanin, M; Demidov, L; Moiseyenko, V; Protsenko, S; Odintsova, S; Semiglazova, T Y; Zukov, R; Lazarev, S; Andreev, A; Nechaeva, M; Makarova, J; Fadeeva, N; Tarasova, A; Kozlova, O; Shustova, M; Garipov, A; Ivanov, R Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1406PFinal results of the concordance analysis of PD-L1 immunohistochemistry (IHC) assays and polymerase chain reaction (PCR) in non-small lung cancer (NSCLC) patients. (23rd October 2018) Authors: Tsimafeyeu, I; Imyanitov, E N; Zavalishina, L; Raskin, G; Povilaitite, P; Savelov, N; Kharitonova, E; Rumyantsev, A; Pugach, I; Andreeva, Y; Petrov, A; Frank, G; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 503PPrognostic factors of chemo-radiotherapy efficacy in patients with locally-advanced rectal cancer. (23rd October 2018) Authors: Fedyanin, M; Tryakin, A; Pokataev, I; Bulanov, A; Sekhina, O; Chekini, D; Gordeev, S; Aliev, V; Kuzmichev, D; Mamedli, Z; Barsukov, Y; Glebovskaya, V; Tkachev, S; Chernykh, M; Kozlov, N; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 586PSequencing of KRAS and NRAS in 1501 colorectal carcinomas reveals significant share of mutations, which are not included in common diagnostic kits. (23rd October 2018) Authors: Imyanitov, E N; Mitiushkina, N V; Kuligina, E S; Holmatov, M; Yanus, G A; Demidova, I; Kekeeva, T; Gordiev, M; Kharitonova, E; Tsimafeyeu, I; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 994PRole of FGFR2 amplification in prognosis of patients with ovarian cancer. (23rd October 2018) Authors: Tyulyandina, A; Demidova, I; Gikalo, M; Tjulandin, S; Tsimafeyeu, I Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-058Trifluridine/tipiracil safety and efficacy in Russian patients with metastatic colorectal cancer and refractory or intolerant to standard chemotherapies: Results of the primary analysis. (2nd July 2019) Authors: Fedyanin, M; Chekini, D; Chubenko, V; Tjulandin, S; Zhabina, A; Amellal, N; Aubel, P; Gandossi, E; Moiseenko, V Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-269Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016. (20th June 2018) Authors: Fedyanin, M; Elsnukaeva, H; Polyanskaya, E; Popova, A; Pokataev, I; Ignatova, E; Bulanov, A; Tryakin, A; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-269Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016. (20th June 2018) Authors: Fedyanin, M; Elsnukaeva, H; Polyanskaya, E; Popova, A; Pokataev, I; Ignatova, E; Bulanov, A; Tryakin, A; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-270Association between duration of oxaliplatin-free interval and effect of reintroduction of oxaliplatin-containing chemotherapy in patients with metastatic colorectal cancer (mCRC). (20th June 2018) Authors: Fedyanin, M; Tryakin, A; Bulanov, A; Popova, A; Ignatova, E; Sekhina, O; Chekini, D; Polyanskaya, E; Elsnukaeva, H; Pokataev, I; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-270Association between duration of oxaliplatin-free interval and effect of reintroduction of oxaliplatin-containing chemotherapy in patients with metastatic colorectal cancer (mCRC). (20th June 2018) Authors: Fedyanin, M; Tryakin, A; Bulanov, A; Popova, A; Ignatova, E; Sekhina, O; Chekini, D; Polyanskaya, E; Elsnukaeva, H; Pokataev, I; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗